These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 2867207)
1. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog. Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists. Sabouni MH; Alkadhi KA; Lokhandwala MF J Pharmacol Exp Ther; 1986 Jan; 236(1):65-70. PubMed ID: 2867216 [TBL] [Abstract][Full Text] [Related]
3. Effect of dopamine receptor activation on ganglionic transmission and cyclic AMP levels in the stellate ganglia and renal arteries of the dog. Sabouni MH; Alkadhi KA; Lokhandwala MF J Pharmacol Exp Ther; 1987 Jan; 240(1):93-8. PubMed ID: 2879905 [TBL] [Abstract][Full Text] [Related]
4. Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission. Satoh Y; Kohli JD; Goldberg LI J Pharmacol Exp Ther; 1989 Oct; 251(1):253-7. PubMed ID: 2571718 [TBL] [Abstract][Full Text] [Related]
5. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat. Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213 [TBL] [Abstract][Full Text] [Related]
6. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat. Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors. Lokhandwala MF; Watkins HO; Sabouni MH; Alkadhi KA J Pharmacol Exp Ther; 1985 Aug; 234(2):337-44. PubMed ID: 2862275 [TBL] [Abstract][Full Text] [Related]
8. Ganglionic dopamine receptors as mediators of the inhibition of neurogenic vasoconstriction produced by fenoldopam. Lokhandwala MF; Sabouni MH J Auton Pharmacol; 1985 Dec; 5(4):301-5. PubMed ID: 2869042 [TBL] [Abstract][Full Text] [Related]
9. The inhibition of ganglionic transmission via presynaptic dopamine DA1 and postsynaptic DA2 receptor activation in the canine cardiac sympathetic ganglia. Mukai M; Kushiku K; Yamada H; Yamada K; Dan K; Furukawa T J Pharmacol Exp Ther; 1996 Nov; 279(2):822-9. PubMed ID: 8930189 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog. Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644 [TBL] [Abstract][Full Text] [Related]
11. Effects of SK&F 85174, a DA-1/DA-2 receptor agonist, on pre- and postganglionic sympathetic neurotransmission to the heart. Dlewati A; Watkins HO; Lokhandwala MF Eur J Pharmacol; 1989 May; 164(2):197-203. PubMed ID: 2569408 [TBL] [Abstract][Full Text] [Related]
12. Facilitation of ganglionic transmission by sulpiride: evidence for an inhibitory role of dopamine in the canine sympathetic ganglion. Horn PT; Kohli JD; Goldberg LI J Pharmacol Exp Ther; 1982 Nov; 223(2):462-8. PubMed ID: 6290639 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog. Kinter LB; Horner E; Mann WA; Weinstock J; Ruffolo RR Chirality; 1990; 2(4):219-25. PubMed ID: 1982058 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. Hahn RA; Wardell JR; Sarau HM; Ridley PT J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs. Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543 [TBL] [Abstract][Full Text] [Related]
16. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed. Dupont AG; Lefebvre RA; Vanderniepen P Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174 [TBL] [Abstract][Full Text] [Related]
18. Dopamine1 receptor agonist and alpha-2 adrenoceptor antagonist effects of fenoldopam in rabbits. Szabo B; Hedler L; Starke K J Pharmacol Exp Ther; 1986 Dec; 239(3):881-6. PubMed ID: 2879034 [TBL] [Abstract][Full Text] [Related]
19. Effects of dopamine receptor and alpha 2-adrenoceptor agonists and antagonists on muscarinic receptor stimulation in cardiac sympathetic ganglia of the dog. Kimura T; Mukaiyama O; Satoh S J Cardiovasc Pharmacol; 1992 Mar; 19(3):382-6. PubMed ID: 1378118 [TBL] [Abstract][Full Text] [Related]
20. Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK & F 85174 in the dog hindlimb. Lokhandwala MF; Watkins HO; Dlewati A Eur J Pharmacol; 1987 Nov; 143(3):383-90. PubMed ID: 2891555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]